← All verdicts
Verdict

Data Unavailable

Every analyzed stock in Data Unavailable — 2,921 companies. Each card shows price, our model's intrinsic value (IV), and how far price sits above or below it. Click any card for the full analysis. This is a research-triage view, not a buy/sell signal.

Educational use only — not investment advice. "Undervalued / fairly valued / overvalued" and every risk score reflect our models vs. price, which can be wrong or based on stale or incomplete data. Always review the company's own financials and SEC filings, and consult a licensed advisor, before acting.
"Data Unavailable" by: Model value (price vs DCF) Owner-earnings return (equity bond)

This lens: price against our probability-weighted DCF value (P/IV). Its own forward record began accruing on 2026-09-10 (daily snapshots); until a year of it exists, the panel below tests the nearest cousin we can measure point-in-time — cheap on book value — and says so.

Market state today: Calm — the S&P 500 closed 2.0% below its 1-year high (as of 2026-09-17). Our rule, the same one used to split every backtest on this site: sell-off = 10% or more below the 1-year high, borderline from 5%, calm otherwise. A further 8.2% fall from here would put us in a sell-off. Since 2006 the market has been in a sell-off 16.6% of the time, across 13 episodes (red bands).
2007200920112013201520172019202120232025
S&P 500 (SPY, adjusted) distance from its trailing 1-year high, weekly. Amber band: borderline (−5% to −10%). Red band: sell-off (below −10%). The dot is today. History to 2026-08-19 from the research database; today from the live feed.
Backtest · point in time · 8,702 entries in the study

Does this screen work? The record for exactly these filters

Screen tested: Proxy: price-to-book ≤ 1.2 (undervalued band has no point-in-time history yet) · bought the day of the annual report, held 12 months
Probable Buy every company that met this screen on the day it filed its annual report, hold 12 months: on average it beat the S&P 500 by +12.6 pts (1,427 entries, 311 companies, very unlikely to be luck). 50% of entries beat the S&P; 25% beat it by 30 points or more; 30% trailed it by 20 points or more. Owning everything instead averaged +1.7 pts, so the screen's edge is +10.9 pts.
+12.6 ptsvs S&P, average
50%beat the S&P
25%up 30+ pts vs S&P
30%down 20+ pts vs S&P
+14.0 ptsvs small caps, 12 mo
−15.1 pts 2019worst year to buy ?
6.1luck check ?
Does the holding period matter?3 mo: +2.3 pts 49% beat6 mo: +4.6 pts 49% beat12 mo: +12.6 pts 50% beat24 mo: +21.8 pts 46% beat3 yr, per yr: +1.3 pts 40% beat
Market state at entryCompany-yearsvs S&P 12 movs small caps
Calm ◀ today1,245+7.9 pts t 4.6+10.1 pts
Sell-off (S&P ≥10% off high)182+44.5 pts t 4.0+40.7 pts
Sector (SEC group)nvs S&P 12 mo3 yrs / yr
Industrials & manufacturing466+13.0 pts t 4.0−2.2 pts
Energy126+7.4 pts t 1.2−7.8 pts
Other115+8.4 pts t 1.8+3.8 pts
Tech hardware & semis113+10.9 pts t 1.6+2.3 pts
Services96+11.9 pts t 2.7+12.2 pts
Retail & consumer87+17.2 pts t 2.1+10.2 pts
Finance & real estate72−1.7 pts t -0.5−2.4 pts
Utilities65+5.6 pts t 0.6−1.2 pts
Construction53+13.2 pts t 1.7−2.4 pts
Biotech & pharma44+47.1 pts t 1.6+10.0 pts
Telecom & media43+14.0 pts t 0.7−6.3 pts
Software & IT services35+39.9 pts t 1.8+1.2 pts

Holds up out of sample? Before 2018: +10.7 pts (n 629, t 6.0). From 2018: +14.0 pts (n 798, t 4.1). Same sign in both halves.

Year2010201120122013201420152016201720182019202020212022202320242025
vs S&P+13 pts+5 pts+14 pts+18 pts−4 pts−4 pts+22 pts+12 pts−3 pts−15 pts+87 pts+8 pts+17 pts−9 pts−7 pts+15 pts
n254310610178841118178991297276108121115

Read the research behind this screen: Price-to-book still sorts, across all sizes → · Test your own combination in the Screen Lab →

Our model values are recomputed daily but were never stored historically, so this band cannot be backtested honestly yet. Daily snapshots began 2026-09-10; a true record accrues from there. Until then the nearest tested cousin is shown — cheap on book value — and labelled as a proxy. Point-in-time: each entry is one company bought at the first close after its 10-K filing date, using only filings available that day, held 12 months; result = total return minus SPY over the same months (vs IWM for 12 months; 3-yr annualised). Survivorship-tilted universe; no costs; read spreads, not levels. Educational, hypothetical, before costs.

Sort by: A–Z Riskiest Most overvalued Most shorted Buyers' strike Largest
FT
FRANKLIN UNIVERSAL TRUST
Valuation N/A
Unknown
Price$7.53
Model IV—
P/IV—
Limited data — see page
FTF
FRANKLIN LTD DURATION INCOME TRUST
Valuation N/A
Unknown
Price$5.68
Model IV—
P/IV—
Limited data — see page
FTHY
FIRST TRUST HIGH YIELD OPPORTUNITIES 2027 TERM FUND
Valuation N/A
Unknown
Price$13.00
Model IV—
P/IV—
Limited data — see page
FTK
FLOTEK INDUSTRIES INC/CN/
Valuation N/A
Basic Materials Risk 42 · Elevated
Price$26.34
Model IV—
P/IV—
Market implies +91.6%/yr vs model +8.0% · above model
FTW
PRESIDIO PRODUCTION Co
Valuation N/A
Energy
Price$10.53
Model IV—
P/IV—
Limited data — see page
FULC
Fulcrum Therapeutics, Inc.
Valuation N/A
Healthcare Risk 44 · Elevated
Price$3.78
Model IV—
P/IV—
Limited data — see page
FUND
SPROTT FOCUS TRUST INC.
Valuation N/A
Unknown
Price$10.38
Model IV—
P/IV—
Limited data — see page
FURY
FURY GOLD MINES LTD
Valuation N/A
Basic Materials Risk 32 · Moderate
Price$0.59
Model IV—
P/IV—
Limited data — see page
FVAV
Fortress Value Acquisition Corp. V
Valuation N/A
Financial Services
Price$10.26
Model IV—
P/IV—
Limited data — see page
FVN
Future Vision II Acquisition Corp.
Valuation N/A
Technology Risk 31 · Moderate
Price$10.30
Model IV—
P/IV—
Limited data — see page
FVNNR
Future Vision II Acquisition Corp.
Valuation N/A
Technology Risk 37 · Moderate
Price$0.22
Model IV—
P/IV—
Limited data — see page
FVNNU
Future Vision II Acquisition Corp.
Valuation N/A
Technology Risk 31 · Moderate
Price$13.50
Model IV—
P/IV—
Limited data — see page
FWDI
Forward Industries, Inc.
Valuation N/A
Financial Services Risk 53 · Elevated
Price$6.55
Model IV—
P/IV—
Market implies +21.9%/yr vs model +2.0% · above model
FXA
Invesco CurrencyShares Australian Dollar Trust
Valuation N/A
Financial Services Risk 32 · Moderate
Price$70.61
Model IV—
P/IV—
Limited data — see page
FXB
Invesco CurrencyShares British Pound Sterling Trust
Valuation N/A
Financial Services Risk 32 · Moderate
Price$129.83
Model IV—
P/IV—
Limited data — see page
FXC
Invesco CurrencyShares Canadian Dollar Trust
Valuation N/A
Financial Services Risk 51 · Elevated
Price$70.52
Model IV—
P/IV—
Limited data — see page
FXE
Invesco CurrencyShares Euro Trust
Valuation N/A
Financial Services Risk 54 · Elevated
Price$107.01
Model IV—
P/IV—
Limited data — see page
FXF
Invesco CurrencyShares Swiss Franc Trust
Valuation N/A
Financial Services Risk 40 · Elevated
Price$107.56
Model IV—
P/IV—
Limited data — see page
FXY
Invesco CurrencyShares Japanese Yen Trust
Valuation N/A
Financial Services Risk 54 · Elevated
Price$59.43
Model IV—
P/IV—
Limited data — see page
GAB
GABELLI EQUITY TRUST INC
Valuation N/A
Unknown
Price$5.53
Model IV—
P/IV—
Limited data — see page
GAIN
GLADSTONE INVESTMENT CORPORATIONDE
Valuation N/A
Unknown Risk 45 · Elevated
Price$15.90
Model IV—
P/IV—
Limited data — see page
GAING
GLADSTONE INVESTMENT CORPORATIONDE
Valuation N/A
Unknown Risk 55 · Elevated
Price$25.17
Model IV—
P/IV—
Limited data — see page
GAINI
GLADSTONE INVESTMENT CORPORATIONDE
Valuation N/A
Unknown Risk 45 · Elevated
Price$25.38
Model IV—
P/IV—
Limited data — see page
GAINZ
GLADSTONE INVESTMENT CORPORATIONDE
Valuation N/A
Unknown Risk 60 · High
Price$24.20
Model IV—
P/IV—
Limited data — see page
GALT
GALECTIN THERAPEUTICS INC
Valuation N/A
Healthcare Risk 40 · Elevated
Price$3.91
Model IV—
P/IV—
Limited data — see page
GAM
GENERAL AMERICAN INVESTORS CO INC
Valuation N/A
Unknown
Price$65.73
Model IV—
P/IV—
Limited data — see page
GAMB
Gambling.com Group Ltd
Valuation N/A
Communication Services Risk 32 · Moderate
Price$1.86
Model IV—
P/IV—
Limited data — see page
GANX
Gain Therapeutics, Inc.
Valuation N/A
Healthcare Risk 42 · Elevated
Price$1.75
Model IV—
P/IV—
Market implies +109.2%/yr vs model +15.0% · above model
GAU
Galiano Gold Inc.
Valuation N/A
Basic Materials Risk 31 · Moderate
Price$2.16
Model IV—
P/IV—
Limited data — see page
GAVA
Grayscale Avalanche Staking ETF
Valuation N/A
Financial Services Risk 53 · Elevated
Price$18.19
Model IV—
P/IV—
Limited data — see page
GBAB
Guggenheim Taxable Municipal Bond & Investment Grade Debt Trust
Valuation N/A
Unknown
Price$13.46
Model IV—
P/IV—
Limited data — see page
GBDC
GOLUB CAPITAL BDC, Inc.
Valuation N/A
Unknown Risk 65 · High
Price$12.79
Model IV—
P/IV—
Limited data — see page
GBR
New Concept Energy, Inc.
Valuation N/A
Energy Risk 35 · Moderate
Price$0.75
Model IV—
P/IV—
Limited data — see page
GBTC
Grayscale Bitcoin Trust ETF
Valuation N/A
Financial Services Risk 36 · Moderate
Price$59.77
Model IV—
P/IV—
Limited data — see page
GCDT
Green Circle Decarbonize Technology Ltd
Valuation N/A
Industrials Risk 42 · Elevated
Price$0.43
Model IV—
P/IV—
Limited data — see page
GCTK
Glucotrack, Inc.
Valuation N/A
Healthcare Risk 42 · Elevated
Price$2.27
Model IV—
P/IV—
Limited data — see page
GCTS
GCT Semiconductor Holding, Inc.
Valuation N/A
Technology Risk 73 · High
Price$1.91
Model IV—
P/IV—
Market implies +25.8%/yr vs model +15.0% · above model
GCV
GABELLI CONVERTIBLE & INCOME SECURITIES FUND INC
Valuation N/A
Unknown
Price$4.58
Model IV—
P/IV—
Limited data — see page
GDC
GD Culture Group Ltd
Valuation N/A
Industrials Risk 28 · Moderate
Price$1.31
Model IV—
P/IV—
Market implies +101.1%/yr vs model +15.0% · above model
GDEV
GDEV Inc.
Valuation N/A
Technology Risk 32 · Moderate
Price$10.98
Model IV—
P/IV—
Limited data — see page
GDHG
GOLDEN HEAVEN GROUP HOLDINGS LTD.
Valuation N/A
Communication Services Risk 43 · Elevated
Price$1.25
Model IV—
P/IV—
Market implies -50.0%/yr vs model -8.0% · below model
GDL
GDL FUND
Valuation N/A
Unknown
Price$8.42
Model IV—
P/IV—
Limited data — see page
GDLC
Grayscale CoinDesk Crypto 5 ETF
Valuation N/A
Financial Services Risk 54 · Elevated
Price$36.32
Model IV—
P/IV—
Limited data — see page
GDO
WESTERN ASSET GLOBAL CORPORATE OPPORTUNITY FUND INC.
Valuation N/A
Unknown
Price$9.93
Model IV—
P/IV—
Limited data — see page
GDOG
Grayscale Dogecoin Trust ETF
Valuation N/A
Financial Services Risk 53 · Elevated
Price$9.92
Model IV—
P/IV—
Limited data — see page
GDS
GDS Holdings Ltd
Valuation N/A
Technology Risk 55 · Elevated
Price$30.82
Model IV—
P/IV—
Limited data — see page
GDTC
CytoMed Therapeutics Ltd
Valuation N/A
Healthcare Risk 39 · Moderate
Price$0.78
Model IV—
P/IV—
Limited data — see page
GDV
GABELLI DIVIDEND & INCOME TRUST
Valuation N/A
Unknown
Price$29.55
Model IV—
P/IV—
Limited data — see page
GECC
Great Elm Capital Corp.
Valuation N/A
Unknown Risk 40 · Elevated
Price$5.98
Model IV—
P/IV—
Limited data — see page
GECCG
Great Elm Capital Corp.
Valuation N/A
Unknown Risk 42 · Elevated
Price$24.85
Model IV—
P/IV—
Limited data — see page
GECCH
Great Elm Capital Corp.
Valuation N/A
Unknown Risk 42 · Elevated
Price$25.25
Model IV—
P/IV—
Limited data — see page
GECCI
Great Elm Capital Corp.
Valuation N/A
Unknown Risk 42 · Elevated
Price$25.45
Model IV—
P/IV—
Limited data — see page
GECCO
Great Elm Capital Corp.
Valuation N/A
Unknown
Price$25.25
Model IV—
P/IV—
Limited data — see page
GEF
GREIF, INC
Valuation N/A
Industrials
Price$82.32
Model IV—
P/IV—
Limited data — see page
GEGGL
Great Elm Group, Inc.
Valuation N/A
Technology Risk 42 · Elevated
Price$24.85
Model IV—
P/IV—
Market implies +42.0%/yr vs model +2.0% · above model
GELS
Gelteq Ltd
Valuation N/A
Healthcare Risk 61 · High
Price$0.70
Model IV—
P/IV—
Limited data — see page
GENB
Generate Biomedicines, Inc.
Valuation N/A
Healthcare Risk 53 · Elevated
Price$15.72
Model IV—
P/IV—
Limited data — see page
GENC
GENCOR INDUSTRIES INC
Valuation N/A
Industrials Risk 55 · Elevated
Price$17.93
Model IV—
P/IV—
Limited data — see page
GERN
GERON CORP
Valuation N/A
Healthcare Risk 55 · Elevated
Price$1.35
Model IV—
P/IV—
Market implies +141.6%/yr vs model +15.0% · above model
GEV
GE Vernova Inc.
Valuation N/A
Technology Risk 41 · Elevated
Price$874.76
Model IV—
P/IV—
Market implies +32.7%/yr vs model +9.7% · above model